Innovative Digital Solutions Temedica’s development of digital health apps and companion tools for chronic conditions like diabetes and psoriasis presents opportunities to collaborate with pharmaceutical companies seeking to enhance patient engagement and adherence through integrated digital platforms.

Strategic Industry Partnerships Partnerships with major pharma players like Bristol Myers Squibb and Novo Nordisk demonstrate Temedica’s position as a key innovator in digital health solutions, making it a compelling partner for companies aiming to leverage real-world data and AI for market access and patient support programs.

Recent Funding Growth The successful Series B funding round totaling €42 million indicates strong investor confidence and growth potential, suggesting additional capacity for expanding service offerings into new therapeutic areas and markets tailored to pharma digital needs.

Focus on Real-World Data With the launch of the Permea data platform, Temedica is positioned to provide high-value insights from real-world evidence, aiding pharma companies in demonstrating product effectiveness and optimizing market strategies.

Technology Enablement Utilizing advanced AI and data infrastructure, Temedica’s solutions can support pharma clients in digital transformation initiatives, creating opportunities to integrate with existing health tech systems and enhance data-driven decision making.